Peptide Therapeutics Market by Type, Type of Manufacturers, Route of Administration, Application Technology - Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 120 Pages

Description

Industry Outlook and Trend Analysis

The Peptide Therapeutics Market was worth USD 19.52 billion in 2014 and is expected to reach approximately USD 42.97 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.16% during the forecast period. Expanding prevalence of cancer and metabolic disorders, for example, obesity, diabetes, and osteoporosis are the key variables contributing toward the adoption of peptide therapeutics over the conjecture time frame. The demand for low-cost and efficient drugs is high because of developing base of affected paediatric populace and predominance of target diseases in countries with a low income. The development is specifically connected with rising interests in drug revelation.

Application Outlook and Trend Analysis

The cancer section ruled in 2016 with revenue share of over USD 1.85 billion. Expanding prevalence of cancer worldwide and expanding prescription of peptide therapeutics for malignancy treatment are the key components in charge of predominance in this fragment. Rising demand for rapid-acting and efficient therapeutics is foreseen to highlight development.

Type Outlook and Trend Analysis

The innovative peptides ruled in 2016 and held a share of around 66.93%, inferable from the expanding ventures by vast pharmaceuticals in R&D for the improvement of novel drugs and high prescription rate. Nonetheless, generics are expected to encounter lucrative growth over the conjecture time frame.

Manufacturing type Outlook and Trend Analysis

The in-house manufacturing section held the biggest share representing more than 60.0% in 2016. Majority of the key players are engaged with developing peptide therapeutics in-house attributable to stringent regulations and increasing expenses of outsourcing. As huge pharmaceutical organizations have legitimate infrastructure for large-scale manufacturing and advanced technology, these organizations favour in-house manufacturing.

Route of administration Outlook and Trend Analysis

The biopharmaceuticals giants are constantly examining new techniques for drug delivery suitable to peptides. Novel drug delivery technologies are presently being evaluated for efficacy with engineered molecules containing advanced PEGylation, trying to enhance performance of drug delivery performance through better methods of drug delivery. Parenteral course of administration commanded in 2016 with a significant share of the market.

Synthesis Technology Outlook and Trend Analysis

The LPPS section ruled with share of more than 45.0% in 2016 attributable to existence of growing demand for unadulterated peptides for improvement of effective therapeutics. Nonetheless, issues, for example, higher usage of time are in charge of switching preferences of consumers to effective and faster methods, for example, SPPS.

Regional Outlook and Trend Analysis

North America commanded the market in 2016. Increasing awareness levels relating to peptide therapeutics products, expanding interest for diagnostics in cancer and other diseases, and developing biotechnology sector are the components contributing toward the strength. Expanding R&D expenditure by government is additionally assessed to enable peptide therapeutics to keep up predominance over the coming years.

Competitive Insights

The leading players in the market are Sanofi, Lonza Group, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novo Nordisk, Teva Pharmaceutical Industries, Novartis, Takeda Pharmaceutical Company, Bristol-Myers Squibb, AstraZeneca and Amgen. Improvement of new products and adopting technological progressions are key methods attempted by the organizations to maintain market position. In addition, expanding collaborations for undertaking trials of new drugs is evaluated to increment competition.

The Peptide Therapeutics Market is segmented as follows-

By Application:


Metabolic
Respiratory
Anti-infection
Dermatology
Renal
Cancers
Cardiovascular Disorder
GIT
Pain
CNS
Others


By Type:


Innovative
Generic


By Type of Manufacturers:


Outsourced
In-house


By Route of Administration:


Oral Route
Mucosal
Parenteral Route
Pulmonary
Others


By Synthesis Technology:


Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Hybrid Technology


By Region


North America


U.S.
Canada
Mexico







Europe


Germany
UK
France
Russia
Italy
Rest of Europe







Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific







South America


Brazil
Argentina
Columbia
South Africa
Rest of South America







Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA




Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2023`
What will be the industry market growth from 2015 to 2023`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Incidences of Metabolic Disorder
3.2.1.2. Presence of Strong Product Pipeline Portfolio
3.2.2. Restraints
3.2.2.1. Stringent Regulations
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)
4.2.4. Russia Market States and Outlook (2014-2023)
4.2.5. Italy Market States and Outlook (2014-2023)
4.2.6. Rest of Europe Market States and Outlook (2014-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2014-2023)
4.3.2. Japan Market States and Outlook (2014-2023)
4.3.3. Korea Market States and Outlook (2014-2023)
4.3.4. India Market States and Outlook (2014-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2014-2023)
4.4.2. Argentina Market States and Outlook (2014-2023)
4.4.3. Columbia Market States and Outlook (2014-2023)
4.4.4. Rest of South America Market States and Outlook (2014-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2014-2023)
4.5.2. UAE Market States and Outlook (2014-2023)
4.5.3. Egypt Market States and Outlook (2014-2023)
4.5.4. Nigeria Market States and Outlook (2014-2023)
4.5.5. South Africa Market States and Outlook (2014-2023)
4.5.6. Rest of MEA Market States and Outlook (2014-2023)
5. Peptide Therapeutics Market, By Type
5.1. Introduction
5.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Type (2014-2018)
5.2.1. Global Peptide Therapeutics Sales and Sales Share by Type (2014-2018)
5.2.2. Global Peptide Therapeutics Revenue and Revenue Share by Type (2014-2018)
5.3. Generic
5.3.1. Global Generic Sales and Growth Rate (2014-2018)
5.4. Innovative
5.4.1. Global Innovative Sales and Growth Rate (2014-2018)
6. Peptide Therapeutics Market, By Application
6.1. Introduction
6.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Application (2014-2018)
6.2.1. Global Peptide Therapeutics Sales and Sales Share by Application (2014-2018)
6.2.2. Global Peptide Therapeutics Revenue and Revenue Share by Application (2014-2018)
6.3. Cancers
6.3.1. Global Cancers Sales and Growth Rate (2014-2018)
6.4. Metabolic
6.4.1. Global Metabolic Sales and Growth Rate (2014-2018)
6.5. Cardiovascular Disorder
6.5.1. Global Cardiovascular Disorder Sales and Growth Rate (2014-2018)
6.6. Respiratory
6.6.1. Global Respiratory Sales and Growth Rate (2014-2018)
6.7. GIT
6.7.1. Global GIT Sales and Growth Rate (2014-2018)
6.8. Anti-infection
6.8.1. Global Anti-infection Sales and Growth Rate (2014-2018)
6.9. Pain
6.9.1. Global Pain Sales and Growth Rate (2014-2018)
6.10. Dermatology
6.10.1. Global Dermatology Sales and Growth Rate (2014-2018)
6.11. CNS
6.11.1. Global CNS Sales and Growth Rate (2014-2018)
6.12. Renal
6.12.1. Global Renal Sales and Growth Rate (2014-2018)
6.13. Other Applications
6.13.1. Global Other Applications Sales and Growth Rate (2014-2018)
7. Peptide Therapeutics Market, By Type Of Manufacturers
7.1. Introduction
7.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Type Of Manufacturers (2014-2018)
7.2.1. Global Peptide Therapeutics Sales and Sales Share by Type Of Manufacturers (2014-2018)
7.2.2. Global Peptide Therapeutics Revenue and Revenue Share by Type Of Manufacturers (2014-2018)
7.3. In-house
7.3.1. Global In-house Sales and Growth Rate (2014-2018)
7.4. Outsourced
7.4.1. Global Outsourced Sales and Growth Rate (2014-2018)
8. Peptide Therapeutics Market, By Route of Administration
8.1. Introduction
8.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Route of Administration (2014-2018)
8.2.1. Global Peptide Therapeutics Sales and Sales Share by Route of Administration (2014-2018)
8.2.2. Global Peptide Therapeutics Revenue and Revenue Share by Route of Administration (2014-2018)
8.3. Parenteral Route
8.3.1. Global Parenteral Route Sales and Growth Rate (2014-2018)
8.4. Oral Route
8.4.1. Global Oral Route Sales and Growth Rate (2014-2018)
8.5. Pulmonary
8.5.1. Global Pulmonary Sales and Growth Rate (2014-2018)
8.6. Mucosal
8.6.1. Global Mucosal Sales and Growth Rate (2014-2018)
8.7. Other Route of Administrations
8.7.1. Global Other Route of Administrations Sales and Growth Rate (2014-2018)
9. Peptide Therapeutics Market, By Technology
9.1. Introduction
9.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Technology (2014-2018)
9.2.1. Global Peptide Therapeutics Sales and Sales Share by Technology (2014-2018)
9.2.2. Global Peptide Therapeutics Revenue and Revenue Share by Technology (2014-2018)
9.3. Solid Phase Peptide Synthesis (SPPS)
9.3.1. Global Solid Phase Peptide Synthesis (SPPS) Sales and Growth Rate (2014-2018)
9.4. Liquid Phase Peptide Synthesis (LPPS)
9.4.1. Global Liquid Phase Peptide Synthesis (LPPS) Sales and Growth Rate (2014-2018)
9.5. Hybrid Technology
9.5.1. Global Hybrid Technology Sales and Growth Rate (2014-2018)
10. Peptide Therapeutics Market, By Region
10.1. Introduction
10.2. Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
10.2.1. Global Peptide Therapeutics Sales by Regions (2014-2018)
10.2.2. Global Peptide Therapeutics Revenue by Regions (2014-2018)
10.3. North America Peptide Therapeutics by Countries
10.3.1. North America Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.3.2. North America Peptide Therapeutics Revenue and Growth Rate (2014-2018)
10.3.3. North America Peptide Therapeutics Sales by Countries (2014-2018)
10.3.4. North America Peptide Therapeutics Revenue (Million USD) by Countries (2014-2018)
10.3.5. U.S.
10.3.5.1. United States Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.3.5.2. United States Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.3.6. Canada
10.3.6.1. Canada Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.3.6.2. Canada Peptide Therapeutics Sales (Millions USD) and Growth Rate (2014-2018)
10.3.7. Mexico
10.3.7.1. Mexico Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.3.7.2. Mexico Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4. Europe Peptide Therapeutics by Countries
10.4.1. Europe Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.2. Europe Peptide Therapeutics Revenue and Growth Rate (2014-2018)
10.4.3. Europe Peptide Therapeutics Sales by Countries (2014-2018)
10.4.4. Europe Peptide Therapeutics Revenue (Million USD) by Countries (2014-2018)
10.4.5. Germany
10.4.5.1. Germany Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.5.2. Germany Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4.6. UK
10.4.6.1. UK Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.6.2. UK Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4.7. France
10.4.7.1. France Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.7.2. France Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4.8. Russia
10.4.8.1. Russia Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.8.2. Russia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4.9. Italy
10.4.9.1. Italy Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.9.2. Italy Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.4.10. Rest of Europe
10.4.10.1. Rest of Europe Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.4.10.2. Rest of Europe Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5. Asia-Pacific
10.5.1. Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.2. Asia-Pacific Peptide Therapeutics Revenue and Growth Rate (2014-2018)
10.5.3. Asia-Pacific Peptide Therapeutics Sales by Countries (2014-2018)
10.5.4. Asia-Pacific Peptide Therapeutics Revenue (Million USD) by Countries (2014-2018)
10.5.5. China
10.5.5.1. China Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.5.2. China Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5.6. Japan
10.5.6.1. Japan Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.6.2. Japan Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5.6.3.
10.5.7. Korea
10.5.7.1. Korea Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.7.2. Korea Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5.8. India
10.5.8.1. India Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.8.2. India Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5.9. Southeast Asia
10.5.9.1. Southeast Asia Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.9.2. Southeast Asia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.5.10. Rest of Asia-Pacific
10.5.10.1. Rest of Asia-Pacific Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.5.10.2. Rest of Asia-Pacific Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.6. South America
10.6.1. South America Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.6.2. South America Peptide Therapeutics Revenue and Growth Rate (2014-2018)
10.6.3. South America Peptide Therapeutics Sales by Countries (2014-2018)
10.6.4. South America Peptide Therapeutics Revenue (Million USD) by Countries (2014-2018)
10.6.5. Brazil
10.6.5.1. Brazil Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.6.5.2. Brazil Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.6.6. Argentina
10.6.6.1. Argentina Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.6.6.2. Argentina Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.6.7. Columbia
10.6.7.1. Columbia Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.6.7.2. Columbia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.6.8. Rest of South America
10.6.8.1. Rest of South America Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.6.8.2. Rest of South America Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7. Middle East and Africa
10.7.1. Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.2. Middle East and Africa Peptide Therapeutics Revenue and Growth Rate (2014-2018)
10.7.3. Middle East and Africa Peptide Therapeutics Sales by Countries (2014-2018)
10.7.4. Middle East and Africa Peptide Therapeutics Revenue (Million USD) by Countries (2014-2018)
10.7.5. Saudi Arabia
10.7.5.1. Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.5.2. Saudi Arabia Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7.6. United Arab Emirates
10.7.6.1. United Arab Emirates Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.6.2. United Arab Emirates Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7.7. Egypt
10.7.7.1. Egypt Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.7.2. Egypt Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7.8. Nigeria
10.7.8.1. Nigeria Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.8.2. Nigeria Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7.9. South Africa
10.7.9.1. South Africa Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.9.2. South Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
10.7.10. Rest of Middle East and Africa
10.7.10.1. Rest of Middle East and Africa Peptide Therapeutics Sales and Growth Rate (2014-2018)
10.7.10.2. Rest of Middle East and Africa Peptide Therapeutics Revenue (Millions USD) and Growth Rate (2014-2018)
11. Company Profiles
11.1. Bachem Holding AG
11.1.1. Business Overview
11.1.2. Product Portfolio
11.1.3. Strategic Developments
11.1.4. Sales, Revenue and Market Share
11.2. Eli Lilly and Company
11.2.1. Business Overview
11.2.2. Product Portfolio
11.2.3. Strategic Developments
11.2.4. Sales, Revenue and Market Share
11.3. Pfizer Inc.
11.3.1. Business Overview
11.3.2. Product Portfolio
11.3.3. Strategic Developments
11.3.4. Sales, Revenue and Market Share
11.4. Amgen Inc.
11.4.1. Business Overview
11.4.2. Product Portfolio
11.4.3. Strategic Developments
11.4.4. Sales, Revenue and Market Share
11.5. Takeda Pharmaceutical Company Limited
11.5.1. Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.5.4. Sales, Revenue and Market Share
11.6. Teva Pharmaceutical
11.6.1. Business Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. Sales, Revenue and Market Share
11.7. Lonza Inc.
11.7.1. Business Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.7.4. Sales, Revenue and Market Share
11.8. Sanofi
11.8.1. Business Overview
11.8.2. Product Portfolio
11.8.3. Strategic Developments
11.8.4. Sales, Revenue and Market Share
11.9. Bristol-Myers Squibb(BMS)
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.9.4. Sales, Revenue and Market Share
11.10.AstraZeneca PLC
11.10.1. Business Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.10.4. Sales, Revenue and Market Share
12. Global Peptide Therapeutics Market Competition, by Manufacturer
12.1. Global Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
12.2. Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
12.3. Global Peptide Therapeutics Price by Manufacturer (2016-2017)
12.4. Top 5 Peptide Therapeutics Manufacturer Market Share
12.5. Market Competition Trend
13. Peptide Therapeutics Market Forecast (2018-2023)
13.1. Global Peptide Therapeutics Sales, Revenue (Millions USD) and Growth Rate (2018-2023)
13.2. Peptide Therapeutics Market Forecast by Regions (2018-2023)
13.2.1. North America Peptide Therapeutics Market Forecast (2018-2023)
13.2.1.1. United States Peptide Therapeutics Market Forecast (2018-2023)
13.2.1.2. Canada Peptide Therapeutics Market Forecast (2018-2023)
13.2.1.3. Mexico Peptide Therapeutics Market Forecast (2018-2023)
13.2.2. Europe Peptide Therapeutics Market Forecast (2018-2023)
13.2.2.1. Germany Peptide Therapeutics Market Forecast (2018-2023)
13.2.2.2. United Kingdom Peptide Therapeuticss Market Forecast (2018-2023)
13.2.2.3. France Peptide Therapeutics Market Forecast (2018-2023)
13.2.2.4. Russia Peptide Therapeutics Market Forecast (2018-2023)
13.2.2.5. Italy Peptide Therapeutics Market Forecast (2018-2023)
13.2.2.6. Rest of the Europe Peptide Therapeutics Market Forecast (2018-2023)
13.2.3. Asia-Pacific Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.1. China Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.2. Japan Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.3. Korea Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.4. India Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.5. Southeast Asia Peptide Therapeutics Market Forecast (2018-2023)
13.2.3.6. Rest of Asia-Pacific Peptide Therapeutics Market Forecast (2018-2023)
13.2.4. South America Peptide Therapeutics Market Forecast (2018-2023)
13.2.4.1. Brazil Peptide Therapeutics Market Forecast (2018-2023)
13.2.4.2. Argentina Peptide Therapeutics Market Forecast (2018-2023)
13.2.4.3. Columbia Peptide Therapeutics Market Forecast (2018-2023)
13.2.4.4. Rest of South America Peptide Therapeutics Market Forecast (2018-2023)
13.2.5. Middle East and Africa Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.1. Saudi Arabia Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.2. UAE Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.3. Egypt Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.4. Nigeria Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.5. South Africa Peptide Therapeutics Market Forecast (2018-2023)
13.2.5.6. Rest of MEA Peptide Therapeutics Market Forecast (2018-2023)
13.3. Peptide Therapeutics Market Forecast by Type (2018-2023)
13.3.1. Global Peptide Therapeutics Sales Forecast by Type (2018-2023)
13.3.2. Global Peptide Therapeutics Sales Market Share Forecast by Type (2018-2023)
13.4. Peptide Therapeutics Market Forecast by Application (2018-2023)
13.4.1. Global Peptide Therapeutics Sales Forecast by Application (2018-2023)
13.4.2. Global Peptide Therapeutics Sales Market Share Forecast by Application (2018-2023)
13.5. Peptide Therapeutics Market Forecast by Type Of Manufacturers (2018-2023)
13.5.1. Global Peptide Therapeutics Sales Forecast by Type Of Manufacturers (2018-2023)
13.5.2. Global Peptide Therapeutics Sales Market Share Forecast by Type Of Manufacturers (2018-2023)
13.6. Peptide Therapeutics Market Forecast by Route of Administration (2018-2023)
13.6.1. Global Peptide Therapeutics Sales Forecast by Route of Administration (2018-2023)
13.6.2. Global Peptide Therapeutics Sales Market Share Forecast by Route of Administration (2018-2023)
13.7. Peptide Therapeutics Market Forecast by Technology (2018-2023)
13.7.1. Global Peptide Therapeutics Sales Forecast by Technology (2018-2023)
13.7.2. Global Peptide Therapeutics Sales Market Share Forecast by Technology (2018-2023)


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Peptide Therapeutics Market.

Request Sample

* mark fields are compulsory